Counsyl Reaches 500,000 Patients Screened, Doubles Patients Served in Just Over One Year
Counsyl’s genetic counselors have logged more than 10,000 hours of counseling, illustrating growing demand for genetic screening
Counsyl, a health technology company that offers DNA screening for diseases that can impact women, men, and their children, announced today that the company has screened more than 500,000 patients, doubling the number of patients served since May 2014.
“Counsyl has experienced tremendous growth, and reaching this milestone is a testament to our dedication to make screening more broadly accessible.”
“We’re incredibly humbled that we’ve earned the trust of so many patients and physicians at critical times in their lives, and we’re still in the very early stages of what’s possible. We still have the opportunity to serve millions of people each year who are planning to get pregnant, are pregnant, or are at-risk for or newly diagnosed with serious cancers. – Ramji Srinivasan, Co-founder and CEO at Counsyl
To meet the growing demand for genetic screening, Counsyl has grown its staff 30 percent since June 2014. The company has also continued to increase accessibility for patients by working with more than 8,000 medical professionals, as well as increasing affordability. Counsyl’s payor network covers approximately 80 percent of patients with commercial insurance, and Counsyl offers an affordable self-pay option for those who are underinsured.